Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, responded today to a survey that says nearly a third of Americans would delay in taking an antibiotic recommended by public health officials in the wake of an anthrax detect.
“Once a positive identification of a trace of anthrax is found, prophylactic antibiotics can be administered to first responders and others that might have come into contact with the deadly bioagent”
The poll, conducted by the Harvard School of Public Health (HSPH), found that if Americans were faced with a significant anthrax threat in their city or town, 89 percent would follow public health officials’ recommendations for prophylactic antibiotics; however, over a third of those respondents (39 percent), would delay in taking those medications.
“Once a positive identification of a trace of anthrax is found, prophylactic antibiotics can be administered to first responders and others that might have come into contact with the deadly bioagent,” said Jacques Tizabi, CEO of Universal Detection Technology. “UNDT’s 5 agent biodetection kits can detect the presence of anthrax and four other agents commonly used as bioweapons in as little as three minutes, allowing for the immediate and appropriate health response to prevent deadly illness,” continued Tizabi.